<DOC>
	<DOC>NCT01435330</DOC>
	<brief_summary>The study will assess the safety, tolerability, drug label and effect in subjects with and without insulin resistance.</brief_summary>
	<brief_title>Safety and Tolerability of BVS857 in Subjects With Insulin Resistance</brief_title>
	<detailed_description />
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Healthy male and female subjects with insulin resistance Subjects with controlled hypertension and hyperlipidemia Smokers History of drug or alcohol use Autonomic dysfunction Significant illness or cardiovascular disease Immunodeficiency disease Other protocoldefined inclusion/exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Safety</keyword>
	<keyword>BVS857</keyword>
	<keyword>insulin resistance</keyword>
</DOC>